CAS 881681-00-1
:Vonoprazan
- 1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine
- Vonoprazan
- 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-
- TAK 438 free form
- 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine
Tak-438
CAS :Formule :C17H16FN3O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :345.3912Vonoprazan
CAS :Vonoprazan (TAK-438 (free base)) is an orally active potassium-competitive acid blocker.Vonoprazan can be used for the treatment of gastroduodenal ulcer andFormule :C17H16FN3O2SDegré de pureté :99.87% - 99.92%Couleur et forme :SolidMasse moléculaire :345.39Vonoprazan
CAS :Produit contrôléStability Hygroscopic
Applications Vonoprazan free base (cas# 881681-00-1) is a useful research chemical.Formule :C17H16FN3O2SCouleur et forme :Light YellowMasse moléculaire :345.39Vonoprazan
CAS :Vonoprazan is an antimicrobial agent that inhibits bacterial growth by binding to the 50S ribosomal subunit. It is a prodrug, which undergoes hydrolysis in vivo to form vonoprazan fumarate. Vonoprazan has been shown to have a long-term efficacy in therapy groups and has been successfully used for the treatment of Helicobacter pylori infection with no evidence of resistance. Vonoprazan fumarate increases the susceptibility of bacteria to fluoroquinolones and other antibiotics, including tetracycline, nonsteroidal anti-inflammatory drugs, and trifluoroacetic acid. Vonoprazan also inhibits the synthesis of bacterial proteins by binding to 16S ribosomal RNA, thereby inhibiting protein synthesis and cell division.
Formule :C17H16FN3O2SDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :345.39 g/mol






